82 related articles for article (PubMed ID: 14961554)
1. Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients.
Kim LH; Shin HD; Park BL; Jung JH; Kim JY; Kim YJ; Lee HS
Hum Mutat; 2003 Jun; 21(6):652-3. PubMed ID: 14961554
[TBL] [Abstract][Full Text] [Related]
2. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
[TBL] [Abstract][Full Text] [Related]
3. TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population.
Cheng Y; Jiang X; Jin J; Luo X; Chen W; Li Q; Zhang C
Biochem Genet; 2019 Feb; 57(1):117-128. PubMed ID: 30073579
[TBL] [Abstract][Full Text] [Related]
4. Association of common polymorphisms in TNFA, NFkB1 and NFKBIA with risk and prognosis of esophageal squamous cell carcinoma.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
PLoS One; 2013; 8(12):e81999. PubMed ID: 24324738
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
6. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
[TBL] [Abstract][Full Text] [Related]
7. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
[TBL] [Abstract][Full Text] [Related]
8. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
9. Association analysis of novel TBX21 variants with asthma phenotypes.
Chung HT; Kim LH; Park BL; Lee JH; Park HS; Choi BW; Hong SJ; Chae SC; Kim JJ; Park CS; Shin HD
Hum Mutat; 2003 Sep; 22(3):257. PubMed ID: 12938094
[TBL] [Abstract][Full Text] [Related]
10. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
11. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.
Sghaier I; Zidi S; Mouelhi L; Dabbech R; Ghazouani E; Brochot E; Stayoussef M; Yacoubi-Loueslati B
Gene; 2015 Sep; 568(2):140-5. PubMed ID: 25982858
[TBL] [Abstract][Full Text] [Related]
12. HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients.
Park BL; Kim YJ; Cheong HS; Lee SO; Han CS; Yoon JH; Park JH; Chang HS; Park CS; Lee HS; Shin HD
Biochem Biophys Res Commun; 2007 Nov; 363(3):776-81. PubMed ID: 17892858
[TBL] [Abstract][Full Text] [Related]
13. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.
Kim JH; Yu SJ; Park BL; Cheong HS; Pasaje CF; Bae JS; Lee HS; Shin HD; Kim YJ
Dig Dis; 2011; 29(3):278-83. PubMed ID: 21829018
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients.
Pan N; Chen K; Qiu J; Sun H; Xu J; Miao F; Shi Q; Jiang W; Jin H; He Y; Xie W; Zhang J
Hum Immunol; 2013 Jun; 74(6):758-63. PubMed ID: 23459080
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
16. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.
Cheng CW; Su JL; Lin CW; Su CW; Shih CH; Yang SF; Chien MH
PLoS One; 2013; 8(2):e56130. PubMed ID: 23457512
[TBL] [Abstract][Full Text] [Related]
17. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression.
Fakhir FZ; Lkhider M; Badre W; Alaoui R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2016 Apr; 39():141-146. PubMed ID: 26827631
[TBL] [Abstract][Full Text] [Related]
18. [Effect of PTPRD rs2279776 gene and interaction with hepatitis B virus mutations on the risk of hepatocellular carcinoma].
Deng Y; Zhang Q; Zhang YW; Han X; Cao GW
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1228-32. PubMed ID: 24518026
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim YJ; Lee HS
Intervirology; 2005; 48(1):10-5. PubMed ID: 15785084
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.
Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
Hepatology; 2014 May; 59(5):1912-20. PubMed ID: 23907815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
